Evidence map›Paper›PMID 39371176›Full record

ArticlemedRxiv : the preprint server for health sciences2024

Plasma glucosylceramide levels are regulated by

Emma N Somerville, Alva James, Christian Beetz, Robert Schwieger, Gal Barrel, Krishna K Kandaswamy, Marius I Iurascu, Peter Bauer, Michael Ta, Hirotaka Iwaki and 4 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Emma N SomervilleThe Neuro (Montréal Neurological Institute-Hospital), McGill University, Montréal, QC, Canada.ORCID 0000-0002-5892-8069
Alva JamesCENTOGENE GmbH, Rostock, Germany.
Christian BeetzCENTOGENE GmbH, Rostock, Germany.
Robert SchwiegerCENTOGENE GmbH, Rostock, Germany.
Gal BarrelCENTOGENE GmbH, Rostock, Germany.
Krishna K KandaswamyLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Marius I IurascuLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Peter BauerCENTOGENE GmbH, Rostock, Germany.ORCID 0000-0001-9414-4555
Michael TaLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
Hirotaka IwakiLaboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-8982-7885
Konstantin SenkevichThe Neuro (Montréal Neurological Institute-Hospital), McGill University, Montréal, QC, Canada.ORCID 0000-0003-3407-5716
Eric YuThe Neuro (Montréal Neurological Institute-Hospital), McGill University, Montréal, QC, Canada.ORCID 0000-0003-3525-4564
Roy N AlcalayDepartment of Neurology, Columbia University Irving Medical Center, New York, NY, USA.ORCID 0000-0002-5717-4875
Ziv Gan-OrThe Neuro (Montréal Neurological Institute-Hospital), McGill University, Montréal, QC, Canada.ORCID 0000-0003-0332-234X

Funding

iPSCs to study Diversity in Alzheimers disease and Alzheimers disease-related dementias (iDA)ZIAAG000546 · NIA · NATIONAL INSTITUTE ON AGING · PI COOKSON, MARK · 2022 to 2025
$12.5M
Intramural NIH HHS ZIA AG000546
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39371176
PMCPMC11451666

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.